Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $8.90 Analyst target: $7.50 Upside: -15.73%
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enable fundamental research, discovery, and preclinical testing for drug development. The company is headquartered in Holliston, Massachusetts.
See the full interactive analysis & chart →Informational only — not investment advice.